The spinal interbody market is expected to hit $2.5 million by 2030, according to a June 7 report. Advancements in spinal surgery technology, increased demand and adoption of minimally invasive surgery are all factors attributed to the projected 2.9 percent growth.
Metal-based implants have more than 45 percent of revenue share in the market and are growing at the highest rate. Factors include the flexibility, robustness and durability of metal-based implants.
Key players in the interbody device market include NuVasive, Medtronic, Stryker and Zimmer Biomet.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.